GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Itonis Inc (OTCPK:ITNS) » Definitions » EPS (Basic)

Itonis (Itonis) EPS (Basic) : $-0.01 (TTM As of Feb. 2008)


View and export this data going back to 2007. Start your Free Trial

What is Itonis EPS (Basic)?

Itonis's basic earnings per share (Basic EPS) for the three months ended in Feb. 2008 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Feb. 2008 was $-0.01.

Itonis's EPS (Diluted) for the three months ended in Feb. 2008 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2008 was $-0.01.

Itonis's EPS without NRI for the three months ended in Feb. 2008 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2008 was -0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Itonis EPS (Basic) Historical Data

The historical data trend for Itonis's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itonis EPS (Basic) Chart

Itonis Annual Data
Trend Nov05 Nov06 Nov07
EPS (Basic)
-0.06 -0.04 -0.02

Itonis Quarterly Data
Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.01 -

Itonis EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Itonis's Basic EPS for the fiscal year that ended in Nov. 2007 is calculated as

Basic EPS (A: Nov. 2007 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.398-0)/71.714
=-0.02

Itonis's Basic EPS for the quarter that ended in Feb. 2008 is calculated as

Basic EPS (Q: Feb. 2008 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.417-0)/83.562
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Itonis  (OTCPK:ITNS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Itonis EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Itonis's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Itonis (Itonis) Business Description

Traded in Other Exchanges
N/A
Address
22600-C Lambert Street, Suite 902, Lake Forest, CA, USA, 92630
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.

Itonis (Itonis) Headlines